The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Easofen Rapid Relief Max Strength 400 mg soft capsules

Clonmel Healthcare LtdPA0126/343/001

Main Information

Trade NameEasofen Rapid Relief Max Strength 400 mg soft capsules
Active SubstancesIbuprofen
Dosage FormCapsule, soft
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/343/001

Group Information

ATC CodeM01AE01 ibuprofen


License statusAuthorised
Licence Issued05/08/2022
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceProduct is not subject to medical prescription, subject to the following conditions; Max. Dose 400mg, Max. Daily Dose 1200mg, Max. Pack Size: 25 (400mg)
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back